200 related articles for article (PubMed ID: 25330284)
21. Cytochrome p450 and vascular homeostasis.
Fleming I
Circ Res; 2001 Oct; 89(9):753-62. PubMed ID: 11679404
[TBL] [Abstract][Full Text] [Related]
22. Cytochrome P450-derived fatty acid epoxides and diols in angiogenesis and stem cell biology.
Frömel T; Naeem Z; Pirzeh L; Fleming I
Pharmacol Ther; 2022 Jun; 234():108049. PubMed ID: 34848204
[TBL] [Abstract][Full Text] [Related]
23. Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids.
Karkhanis A; Tram NDT; Chan ECY
Biochem Pharmacol; 2017 Dec; 146():188-198. PubMed ID: 28958841
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases.
Schunck WH; Konkel A; Fischer R; Weylandt KH
Pharmacol Ther; 2018 Mar; 183():177-204. PubMed ID: 29080699
[TBL] [Abstract][Full Text] [Related]
25. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
Shahabi P; Siest G; Visvikis-siest S
Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
[TBL] [Abstract][Full Text] [Related]
26. [Essential fatty acids and lipid mediators. Endocannabinoids].
Caramia G
Pediatr Med Chir; 2012; 34(2):65-72. PubMed ID: 22730630
[TBL] [Abstract][Full Text] [Related]
27. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
Huang H; Weng J; Wang MH
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
[TBL] [Abstract][Full Text] [Related]
28. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
29. Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation.
Loot AE; Popp R; Fisslthaler B; Vriens J; Nilius B; Fleming I
Cardiovasc Res; 2008 Dec; 80(3):445-52. PubMed ID: 18682435
[TBL] [Abstract][Full Text] [Related]
30. Role of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome.
Dos Santos LRB; Fleming I
Prostaglandins Other Lipid Mediat; 2020 Jun; 148():106407. PubMed ID: 31899373
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450-derived epoxyeicosatrienoic acids and pulmonary hypertension: central role of transient receptor potential C6 channels.
Loot AE; Fleming I
J Cardiovasc Pharmacol; 2011 Feb; 57(2):140-7. PubMed ID: 20588188
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium.
Vriens J; Owsianik G; Fisslthaler B; Suzuki M; Janssens A; Voets T; Morisseau C; Hammock BD; Fleming I; Busse R; Nilius B
Circ Res; 2005 Oct; 97(9):908-15. PubMed ID: 16179585
[TBL] [Abstract][Full Text] [Related]
33. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
[TBL] [Abstract][Full Text] [Related]
34. CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy.
Chen C; Wang DW
Curr Top Med Chem; 2013; 13(12):1454-69. PubMed ID: 23688135
[TBL] [Abstract][Full Text] [Related]
35. The cytochrome P450 pathway in angiogenesis and endothelial cell biology.
Fleming I
Cancer Metastasis Rev; 2011 Dec; 30(3-4):541-55. PubMed ID: 22009065
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.
Ulu A; Harris TR; Morisseau C; Miyabe C; Inoue H; Schuster G; Dong H; Iosif AM; Liu JY; Weiss RH; Chiamvimonvat N; Imig JD; Hammock BD
J Cardiovasc Pharmacol; 2013 Sep; 62(3):285-97. PubMed ID: 23676336
[TBL] [Abstract][Full Text] [Related]
37. Lipid-metabolizing CYPs in the regulation and dysregulation of metabolism.
Bishop-Bailey D; Thomson S; Askari A; Faulkner A; Wheeler-Jones C
Annu Rev Nutr; 2014; 34():261-79. PubMed ID: 24819323
[TBL] [Abstract][Full Text] [Related]
38. Epoxyeicosatrienoic acids regulate Trp channel dependent Ca2+ signaling and hyperpolarization in endothelial cells.
Fleming I; Rueben A; Popp R; Fisslthaler B; Schrodt S; Sander A; Haendeler J; Falck JR; Morisseau C; Hammock BD; Busse R
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2612-8. PubMed ID: 17872452
[TBL] [Abstract][Full Text] [Related]
39. Cytochrome P450-dependent eicosanoid production and crosstalk.
Fleming I
Curr Opin Lipidol; 2011 Oct; 22(5):403-9. PubMed ID: 21825980
[TBL] [Abstract][Full Text] [Related]
40. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases.
Zordoky BN; El-Kadi AO
Pharmacol Ther; 2010 Mar; 125(3):446-63. PubMed ID: 20093140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
